BioVaxys Technology Corp.
BioVaxys Technology Corp.
CSE Index:
CSE CompositeCurrency:
CAD BioVaxys Technology Corp. is a British Columbia-registered biopharmaceuticals company based in Ontario, Canada that is developing BVX-0918, a personalized immunotherapeutic vaccine using our proprietary HapTenix© 'neoantigen' tumor cell construct platform for treating refractive late stage ovarian cancer. BioVaxys is also exploring vaccines for additional cancers and infectious diseases based on its HapTenix©platform through academic and other collaborations.
BioVaxys Technology Corp. (BIOV)
0.055
0.00 (0.00%)
BioVaxys Technology Corp. (BIOV)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Bid Size
20,000
Bid Price
0.05
Ask Price
0.055
Ask Size
93,000
Volume
198,302
Last Price
0.055
Tick
Net Change
Prev Close
0.055
Open
0.05
Day High
0.055
Day Low
0.05
52 Week High
0.095
52 Week Low
0.04
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
65,000
Bid Price
0.045
Ask Price
0.00
Ask Size
0
Volume
20,000
Last Price
0.045
Tick
Net Change
Prev Close
0.045
Open
0.045
Day High
0.045
Day Low
0.045
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
20,000
Bid Price
0.05
Ask Price
0.055
Ask Size
93,000
Volume
198,302
Last Price
0.055
Tick
Net Change
Prev Close
0.055
Open
0.05
Day High
0.055
Day Low
0.05
52 Week High
0.095
52 Week Low
0.04
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
65,000
Bid Price
0.045
Ask Price
0.00
Ask Size
0
Volume
20,000
Last Price
0.045
Tick
Net Change
Prev Close
0.045
Open
0.045
Day High
0.045
Day Low
0.045
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| W.D. Latimer Co. Limited | 15,000 | 0.05 | 0.055 | 38,000 | TD Securities Inc. |
| TD Securities Inc. | 5,000 | 0.05 | 0.055 | 10,000 | National Bank Financial Inc. |
| W.D. Latimer Co. Limited | 25,000 | 0.045 | 0.055 | 45,000 | Anonymous |
| TD Securities Inc. | 15,000 | 0.045 | 0.06 | 6,000 | RBC Capital Markets |
| CIBC World Markets Inc. | 20,000 | 0.045 | 0.06 | 70,000 | Anonymous |
| RBC Capital Markets | 37,000 | 0.045 | 0.06 | 100,000 | TD Securities Inc. |
| CIBC World Markets Inc. | 25,000 | 0.045 | 0.06 | 80,000 | Anonymous |
| TD Securities Inc. | 23,000 | 0.045 | 0.06 | 1,000 | National Bank Financial Inc. |
| National Bank Financial Inc. | 1,000 | 0.045 | 0.06 | 1,000 | National Bank Financial Inc. |
| National Bank Financial Inc. | 11,000 | 0.045 | 0.06 | 1,000 | National Bank Financial Inc. |
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| Anonymous | 35,000 | 0.045 | 0.00 | 0 | |
| Anonymous | 30,000 | 0.045 | 0.00 | 0 | |
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 2 | 20,000 | 0.05 | 0.055 | 93,000 | 3 |
| 10 | 267,000 | 0.045 | 0.06 | 295,000 | 9 |
| 11 | 184,000 | 0.04 | 0.065 | 206,000 | 17 |
| 2 | 35,000 | 0.035 | 0.07 | 100,000 | 9 |
| 1 | 50,000 | 0.03 | 0.075 | 1,688,000 | 6 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 2 | 65,000 | 0.045 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
|---|---|---|---|---|---|---|
| Feb 28, 20:58 | 0.055 | 0.00 | 5,000 | Anonymous | TD Securities Inc. | CSE |
| Feb 28, 20:55 | 0.055 | 0.00 | 10,000 | Anonymous | TD Securities Inc. | CSE |
| Feb 28, 16:46 | 0.05 | -0.005 | 2,000 | CIBC World Markets Inc. | Anonymous | CSE |
| Feb 28, 16:45 | 0.05 | -0.005 | 3,000 | Anonymous | Anonymous | CSE |
| Feb 28, 16:44 | 0.05 | -0.005 | 10,000 | National Bank Financial Inc. | Anonymous | CSE |
Company Info
Address
146 Thirtieth Street
Suite 100
Etobicoke, ON M8W 3C4
CanadaPhone
646-452-7000Email
jpassin@biovaxys.comWebsite
https://biovaxys.com/Listing date
Wednesday, November 21, 2018Transfer Agent
Odyssey Trust CompanyEmail
news@biovaxys.comAuditor
Dale Matheson Carr-Hilton Labonte LLPSEDAR Information
Filing Type
Any
News Releases
Material Change Report
Management's Discussion & Analysis
Financial Statements
Timeframe
1 week1 month3 month6 month1 yearAll Time
BioVaxys Technology Corp.
Date:
Jan 2, 2025
BioVaxys Technology Corp.
Date:
Dec 20, 2024
BioVaxys Technology Corp.
Date:
Nov 25, 2024
BioVaxys Technology Corp.
Date:
Oct 15, 2024
BioVaxys Technology Corp.
Date:
Oct 3, 2024
BioVaxys Technology Corp.
Date:
Sep 18, 2024
BioVaxys Technology Corp.
Date:
Aug 10, 2024
BioVaxys Technology Corp.
Date:
Aug 8, 2024
BioVaxys Technology Corp.
Date:
Jul 9, 2024
BioVaxys Technology Corp.
Date:
Jul 9, 2024
BioVaxys Technology Corp.
Date:
Jun 4, 2024
BioVaxys Technology Corp.
Date:
May 16, 2024
BioVaxys Technology Corp.
Date:
May 7, 2024
BioVaxys Technology Corp.
Date:
Apr 26, 2024
BioVaxys Technology Corp.
Date:
Mar 5, 2024
BioVaxys Technology Corp.
Date:
Mar 5, 2024
BioVaxys Technology Corp.
Date:
Mar 5, 2024
BioVaxys Technology Corp.
Date:
Feb 22, 2024
BioVaxys Technology Corp.
Date:
Feb 22, 2024
BioVaxys Technology Corp.
Date:
Nov 14, 2023
BioVaxys Technology Corp.
Date:
Apr 6, 2023
BioVaxys Technology Corp.
Date:
Mar 3, 2023
BioVaxys Technology Corp.
Date:
Mar 3, 2023
BioVaxys Technology Corp.
Date:
May 19, 2022
BioVaxys Technology Corp.
Date:
May 19, 2022
BioVaxys Technology Corp.
Date:
Feb 28, 2022
BioVaxys Technology Corp.
Date:
Feb 28, 2022
BioVaxys Technology Corp.
Date:
Jul 23, 2021
BioVaxys Technology Corp.
Date:
Apr 30, 2021
BioVaxys Technology Corp.
Date:
Mar 10, 2021
BioVaxys Technology Corp.
Date:
Mar 10, 2021
BioVaxys Technology Corp.
Date:
Mar 1, 2021
BioVaxys Technology Corp.
Date:
Mar 1, 2021
BioVaxys Technology Corp.
Date:
Oct 13, 2020
BioVaxys Technology Corp.
Date:
Sep 8, 2020
BioVaxys Technology Corp.
Date:
Apr 28, 2020
BioVaxys Technology Corp.
Date:
Feb 27, 2020
BioVaxys Technology Corp.
Date:
Feb 27, 2020
BioVaxys Technology Corp.
Date:
Apr 30, 2019
BioVaxys Technology Corp.
Date:
Feb 15, 2019
BioVaxys Technology Corp.
Date:
Dec 4, 2018
BioVaxys Technology Corp.
Date:
Nov 29, 2018
Company Info
Address
146 Thirtieth Street
Suite 100
Etobicoke, ON M8W 3C4
CanadaPhone
646-452-7000Email
jpassin@biovaxys.comWebsite
https://biovaxys.com/Listing date
Wednesday, November 21, 2018Transfer Agent
Odyssey Trust CompanyEmail
news@biovaxys.comAuditor
Dale Matheson Carr-Hilton Labonte LLPCapitalization
Issued & Outstanding:
287372073Reserved for Issuance:
139701394Company Officers
James Passin, CEO
Kenneth Kovan, COO & President
Christopher Cherry, Chief Financial Officer
James Passin, Chief Executive Officer
Christopher Cherry, Chief Financial Officer
Kenneth Kovan, Chief Operating Officer and President
Bulletins
16/07/2024
2024-0715 - Reinstatement - BioVaxys Technology Corp. (BIOV)
le 16 juillet/July 2024
Effective immediately, BioVaxys Technology Corp. will be reinstated for trading.
The Company has rectified the situation that gave rise to the suspension.
____________________________
Avec effet immédiat, BioVaxys Technology Corp. sera réintégrée à la négociation.
La Société a rectifié la situation qui a donné lieu à la suspension.
CSE Filings
